A total of 49 institutions have reported a stake in Aardvark Therapeutics, Inc. (NASDAQ:AARD) as of September 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Decheng Capital LLC | 30 Sep, 2025 | 3,917,299 | 0 | 0.00% | $52,060,903.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 1,359,883 | 85,799 | 6.73% | $18,072,846.00 |
| Laurion Capital Management LP | 30 Sep, 2025 | 1,049,721 | 60,653 | 6.13% | $13,950,792.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 555,721 | 94,744 | 20.55% | $7,385,532.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 30 Sep, 2025 | 350,000 | 175,000 | 100.00% | $4,651,500.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 319,623 | 253,983 | 386.93% | $4,247,790.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 309,465 | 103,670 | 50.38% | $4,112,790.00 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 306,912 | 20,105 | 7.01% | $4,078,861.00 |
| Schonfeld Strategic Advisors LLC | 30 Sep, 2025 | 253,752 | -25,506 | -9.13% | $3,372,361.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 194,035 | 57,108 | 41.71% | $2,578,990.00 |
| Cresset Asset Management, LLC | 30 Sep, 2025 | 146,783 | 146,783 | 0.00% | $1,950,746.00 |
| CANTOR FITZGERALD, L. P. | 30 Sep, 2025 | 96,682 | 20,000 | 26.08% | $1,284,904.00 |
| STATE STREET CORP | 30 Sep, 2025 | 93,005 | 55,693 | 149.26% | $1,236,036.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 68,462 | 59,502 | 664.08% | $909,860.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 63,569 | 48,145 | 312.14% | $844,832.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 57,197 | 12,112 | 26.86% | $760,149.00 |
| BNP PARIBAS FINANCIAL MARKETS | 30 Sep, 2025 | 56,546 | 21,052 | 59.31% | $751,496.00 |
| UBS Group AG | 30 Sep, 2025 | 54,728 | 2,804 | 5.40% | $727,335.00 |
| BARCLAYS PLC | 30 Sep, 2025 | 39,926 | -10,632 | -21.03% | $530,617.00 |
| TWO SIGMA ADVISERS, LP | 30 Sep, 2025 | 25,700 | 25,700 | 0.00% | $341,553.00 |